³í¹®) "Favorable Q1XX Out come of Post-Transplantation Cyclophosphamide Haploidentical Peripheral BloodStem Cell Transplantationwith Targeted Busulfan-Based Myeloablative Conditioning Using Intensive Pharmacokinetic Monitoringin Pediatric Patients" ¼¿ï´ëº´¿ø ¼Ò¾Æû¼Ò³â°ú °ÇüÁø(»çÁø), È«°æÅà ±³¼öÆÀ